Kyttaro’s primary near-term focus is MSC-Klotho in neurodegenerative disease and longevity. MSC-AAT is prepared for Phase I clinical initiation in the US, building on its Phase I/II regulatory approval in Germany. Kyttaro welcomes partnerships with CDMOs, clinical research organisations, academic institutions, and investors.
We invite interested partners to contact us for more details.
Academic and Research Partners

Kyttaro has submitted an SBIR grant proposal to the NIH for traumatic brain injury in partnership with CHOP. Dr. Todd Kilbaugh, Director of the Resuscitation Science Center at CHOP, serves as co-PI on the grant application for TBI. Dr. Stephan Grupp, Director of the Cancer Immunotherapy Program, is in discussions with Kyttaro regarding MSC-Cyt combination CAR-T cell therapies.

Kyttaro is developing a grant proposal to the NIH in partnership with Johns Hopkins Medicine for ischaemic heart disease using MSC-Klotho. Dr. Gordon Tomaselli, Dean Emeritus of Albert Einstein College of Medicine and Adjunct Professor at Johns Hopkins, leads the group in research discussions with Kyttaro on MSC-Klotho for cardiac arrest.
Industry Partnerships
Arnold & Porter is an international law firm with deep expertise in life sciences, regulatory matters, and emerging company representation. They serve as Kyttaro’s US corporate counsel.

Parexel is one of the world’s leading global clinical research organisations (CRO) and our initial partner for clinical trials management. Over the past five years, Parexel has provided regulatory, clinical and technology project services for around 20 regenerative medicine projects and more than 250 cell and gene therapy projects.

HERTIN & Partner is a law firm focused on the protection of inventions, creative activities, trademarks and freedom of action in competitive marketplaces in Germany and beyond. They have served as patent counsel on Kyttaro’s patent portfolio since the inception of the technology.

Alien Technology Transfer USA Inc. offers tailored business support exclusively for pioneering startups and small businesses. With expertise spanning diverse industries, the Alien Technology firm excels in providing strategic counsel that enhances growth, fosters competitive edge, and boosts financial performance.
alientt.com

Builds @ Banc programme – a dedicated service for early-stage startups offering tailored banking solutions and introductions to the Banc’s network of investors and advisors. Kyttaro has been accepted into the Builds @ Banc programme, providing strategic financial and network support.
BioLabs for Advanced Therapeutics Philadelphia – The 30,000 sq ft incubator features nine conference rooms, premium event space and a variety of specialized support labs focusing on microbiology, microscopy, process development and more. BioLabs will establish ancillary operations in Munich in 2026.



